Flowcytometric analysis of lymphocytapheresis in a patient with recurrent FSGS after renal transplant

1Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

Frequently, focal segmental glomerulosclerosis (FSGS) recurs after renal transplantation, resulting in poor graft survival. Pathological mechanisms of the recurrence are still unknown, but both B and T cell disorders are suspected based on much evidence. This supports theoretical benefits using plasma exchange (PE) and lymphocytapheresis (LCAP). A renal transplant was performed for a 35-year-old woman, who suffered steroid-resistant FSGS and developed to chronic kidney disease stage 5D at 31 years old. We treated the patient with recurrent FSGS by LACP and examined whether peripheral neutrophils were dynamically changed after the therapy. Further, we performed flowcytometric analysis to examine lymphocyte fractions before and after LCAP. The decrease of helper (CD4 positive) and memory (CD4 and CD45RO positive) T cells was prominent after LCAP. Although B cells were at the nadir because of rituximab treatment, LCAP also decreased peripheral B cells. These suggest that LCAP has the potential to suppress the activities of recurrent FSGS after renal transplant. © 2011 The Japanese Society of Internal Medicine.

Cite

CITATION STYLE

APA

Okano, K., Sugimoto, H., Jinnai, H., Iwasaki, T., Takano, M., Tsukada, M., … Akiba, T. (2011). Flowcytometric analysis of lymphocytapheresis in a patient with recurrent FSGS after renal transplant. Internal Medicine, 50(24), 3009–3012. https://doi.org/10.2169/internalmedicine.50.6088

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free